Mission
R3 Stem Cell works as an effective all-encompassing research-oriented framework while relieving the pain and agony of all our patients who are suffering from several chronic, acute, and degenerative diseases through the innovative methods of regenerative medicine therapy. R3 Stem Cell aims to enhance the quality of life and generate new knowledge points through high standard research practices as our stem cell specialists strive to cure diseases affecting millions of lives. R3 Stem Cell as a priority acknowledges the underlying needs in the countries and regions we are currently serving and to the ones where we will soon start our operations.
Research
R3 Stem Cell is completely devoted while we carry out our high standard and ethically driven research practices as stated in our mission statement. All clinical departments are actively engaged in research in their respective area of expertise. R3 Stem Cell is conducting several ongoing types of research simultaneously. R3 Stem Cell is committed to offering excellence as we perform research in different departments:
- Clinical research office (CRO)
- Clinical data management (CDM)
- Basic science research laboratory
- Guidelines for research
- Research publications
Clinical Research Office
Clinical Research Office (CRO) is creating a fully functional, strong regenerative medicine and stem cell research community for knowledge management and knowledge sharing while communicating effectively to all stakeholders. This community is involved in a range of key tasks concerning our research practices. CRO is also involved in the conduction and dissemination of research principles, which define the scientific standards and code of conduct of research that should be followed by all researchers.
CRO is actively involved in several research studies while being in collaboration with internationally leading researchers. To ensure that all research conducted at the Hospital is in accordance with internationally recognized guidelines; our research guidelines include a well-defined selection and review process for all research activities, to ensure the safety of rights and well-being of research subjects including all ethical best practices and the required consents from the participants of the particular research studies.
A core task of CRO is the coordination of clinical trials. For the time, CRO has aided in clinical trials in a diverse range of therapeutic areas. Well-trained clinical research officers are the main advocates of patients involved in all clinical trials we are part of.
Physician investigators of R3 Stem Cell Pakistan are eager to do their research into the causes and treatments of several serious diseases. In addition, the existing information has also been increasingly harnessed to gather crucial evidence to answer certain research questions in the form of retrospective studies.
CRO team has had the privilege to represent the institute in national and international conferences and research-based meetings.
Clinical Data Management
The Clinical Data Management (CDM) staff is responsible for processing and producing summaries on cases that are part of the research.
Basic Science Research Laboratory
In today’s world where the ‘New Normal’ is prevalent, our ultimate aim is to make the outcome of our research into a practical measure for the patients’ well-being. The Basic Science Research Laboratory (BSRL) is provided to conduct cellular and stem cell studies. The lab is also engaged in investigating the use of Stem Cells in treating multiple diseases. Studies are also being conducted with the hope to cure chronic diseases and lessen their impact on future generations.
Guidelines for Research
Guidelines for obtaining scientific and ethical approval for research:
- New scientific opportunities and ethical challenges in the conduct of Stem Cell research, which is on the horizon must be addressed promptly to ensure that science and medical care proceed in a socially responsible and ethically acceptable fashion
- This research should be superintended by qualified investigators and coordinated in a way that maintains public confidence, which ensures that the information gained will be trustworthy, reliable, accessible, and responsive to scientific uncertainties and is prioritized on health needs
- Doctors and Stem Cell receivers need to be confident that the evidence they use to make important healthcare decisions are always careful, accurate, and unbiased
- Physicians and researchers owe their primary duty of care to patients and/or research participants
- The clinical, emotional, and psychosocial risks to the donor are minimized, and/or outcomes are more beneficial to the donor and the recipients
- No babies and mothers should be harmed during the process of cutting the umbilical cord and procuring the Mesenchymal Cells with maximum safety
- Ensure there are no adverse effects and patient safety remains the priority
- Highlight the responsibility of all groups communicating Stem Cell science and medicine: scientists, clinicians, industry, science communicators, and media, to present accurate, balanced reports of progress and setbacks
- Ensure the protection of patients and the judicious use of resources by involving governmental agencies (e.g., DRAP, HOTA) to regulate the cellular product for medical therapy
- Application of Stem Cell-based interventions outside formal research settings should be evidence-based, subject to independent expert review, and serve patients’ best interests
Research Publications
R3 Stem Cell has posed great emphasis on research and findings. R3 Stem Cell holds pride in providing excellent research opportunities to trainees and healthcare professionals. R3 Stem Cell encourages its members to represent their research findings in many reputable meetings, both, locally and globally. Several pilot and commercial studies are in the queue of progress.